Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Han, Fang  [Clear All Filters]
2023
Xu L, Han F, Zhu L, Ding W, Zhang K, Kan C, Hou N, Li Q, Sun X. Advances in understanding the role and mechanisms of tumor stem cells in HER2-positive breast cancer treatment resistance (Review). Int J Oncol. 2023;62(4).
Ma H, Qi G, Han F, Gai P, Peng J, Kong B. HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway. Cell Commun Signal. 2023;21(1):144.
Zhai Y, Yang L, Zheng W, Wang Q, Zhu Z, Han F, Hao Y, Ma S, Cheng G. A precise design strategy for a cell-derived extracellular matrix based on CRISPR/Cas9 for regulating neural stem cell function. Biomater Sci. 2023.
Huang L, Han F, Huang Y, Liu J, Liao X, Cao Z, Li W. Sphk1 deficiency induces apoptosis and developmental defects and premature death in zebrafish. Fish Physiol Biochem. 2023.
2020
Gao M-L, Lei X-L, Han F, He K-W, Jin S-Q, Zhang Y-Y, Jin Z-B. Patient-Specific Retinal Organoids Recapitulate Disease Features of Late-Onset Retinitis Pigmentosa. Front Cell Dev Biol. 2020;8:128.
2019
Han F, Guan X, Guo W, Lu B. Therapeutic potential of a TrkB agonistic antibody for ischemic brain injury. Neurobiol Dis. 2019.
2013
Zhao X, Ding H-F, Guo C-S, Lu X-J, Xu M, Xing J, Han F, Wang L, Lu G, Liu G-Q. [In vitro effects of mesenchymal stem cells on secreting function of T lymphocytes and CD4⁺CD25⁺ T cells from patients with immune thrombocytopenia]. Zhonghua Xue Ye Xue Za Zhi. 2013;34(12):1015-9.